D. Banerjee
- Impact of sputum bacteria on airway inflammation and health status in clinical stable COPDBy D. Banerjee, O.A. Khair and D. HoneybourneD. Banerjee1Dept of Respiratory Medicine, City Hospital, and 2Dept of Respiratory Medicine, Birmingham Heartlands Hospital, Birmingham, UKO.A. Khair1Dept of Respiratory Medicine, City Hospital, and 2Dept of Respiratory Medicine, Birmingham Heartlands Hospital, Birmingham, UKD. Honeybourne1Dept of Respiratory Medicine, City Hospital, and 2Dept of Respiratory Medicine, Birmingham Heartlands Hospital, Birmingham, UK
- Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysisBy Giovanni Battista Migliori, Giovanni Sotgiu, Neel R. Gandhi, Dennis Falzon, Kathryn DeRiemer, Rosella Centis, Maria-Graciela Hollm-Delgado, Domingo Palmero, Carlos Pérez-Guzmán, Mario H. Vargas, Lia D'Ambrosio, Antonio Spanevello, Melissa Bauer, Edward D. Chan, H. Simon Schaaf, Salmaan Keshavjee, Timothy H. Holtz, Dick Menzies and The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TBGiovanni Battista Migliori1World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate15Both authors contributed equallyGiovanni Sotgiu2Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Sassari15Both authors contributed equallyNeel R. Gandhi3Dept of Medicine and Dept of Epidemiology and Population Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY3Dept of Medicine and Dept of Epidemiology and Population Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NYDennis Falzon4Stop TB Dept, World Health Organization, Geneva, SwitzerlandKathryn DeRiemer5School of Medicine, University of California Davis, Davis, CARosella Centis1World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateMaria-Graciela Hollm-Delgado6Montreal Chest Institute, McGill University, Montreal, QC, CanadaDomingo Palmero7Pulmonology Division, Hospital F. J. Muñiz, Buenos Aires, ArgentinaCarlos Pérez-Guzmán8Instituto de Servicios de Salud del Estado de Aguascalientes, Unidad de Medicina Ambulatoria Aguascalientes, Instituto Mexicano del Seguro Social, AguascalientesMario H. Vargas9Instituto Nacional de Enfermedades Respiratorias, and Medical Research Unit in Respiratory Diseases, Instituto Mexicano del Seguro Social, Mexico City, MexicoLia D'Ambrosio1World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateAntonio Spanevello10Università degli Studi dell’ Insubria, Varese and Division of Pneumology, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyMelissa Bauer6Montreal Chest Institute, McGill University, Montreal, QC, CanadaEdward D. Chan11Pulmonary Dept, Denver Veterans Affair Medical Center and National Jewish Health, Denver, COH. Simon Schaaf12Desmond Tutu TB Centre, Dept of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South AfricaSalmaan Keshavjee13Dept of Global Health and Social Medicine, Harvard Medical School, Boston, MATimothy H. Holtz14Centers for Disease Control and Prevention, Atlanta, GA, USADick Menzies6Montreal Chest Institute, McGill University, Montreal, QC, Canada16A full list of the Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB members can be found in the Acknowledgements section
- Efficacy of BiPAP AutoSV advanced in subjects with congestive heart failure and central apneaBy Winifried J. Randerath, D. Banerjee, M. Treml, W. Galetke, C. Priegnitz, A. Ali and S. TaheriWinifried J. Randerath1Institut für Pneumologie, Krankenhaus Bethanien gGmbH, Solingen, GermanyD. Banerjee2Department of Respiratory Medicine, Birmingham Heartland Hospital, Birmingham, United KingdomM. Treml1Institut für Pneumologie, Krankenhaus Bethanien gGmbH, Solingen, GermanyW. Galetke1Institut für Pneumologie, Krankenhaus Bethanien gGmbH, Solingen, GermanyC. Priegnitz1Institut für Pneumologie, Krankenhaus Bethanien gGmbH, Solingen, GermanyA. Ali2Department of Respiratory Medicine, Birmingham Heartland Hospital, Birmingham, United KingdomS. Taheri2Department of Respiratory Medicine, Birmingham Heartland Hospital, Birmingham, United Kingdom
- Outcomes for multidrug-resistant tuberculosis patients with and without resistance to fluoroquinolones and second-line injectable drugs: A meta-analysis of individual patient dataBy G.B. Migliori, S. Ahuja, D. Ashkin, M. Avendano, R. Banerjee, M. Bauer, J. Bayona, M. Becerra, A. Benedetti, M. Burgos, R. Centis, E.D. Chan, C.-Y. Chiang, H. Cox, L. D'Ambrosio, K. DeRiemer, N.H. Dung, D. Enarson, K. Flanagan, J. Flood, M.L. Garcia-Garcia, N. Gandhi, R. Granich, M.G. Hollm-Delgado, T.H. Holtz, M. Iseman, L. Jarlsberg, S. Keshavjee, H.R. Kim, W.-J. Koh, J. Lancaster, C. Lange, W.C.M. de Lange, V. Leimane, C.C. Leung, J. Li, S. Mishustin, C. Mitnick, M. Narita, P. O'Riordan, M. Pai, D. Palmero, S.K. Park, G. Pasvol, J. Pena, C. Pérez-Guzmán, M. Quelapio, A. Ponce-de-Leon, V. Riekstina, J. Robert, S. Royce, H.S. Schaaf, K.J. Seung, L. Shah, T.S. Shim, S.S. Shin, Y. Shiraishi, J. Sifuentes-Osornio, G. Sotgiu, M.J. Strand, P. Tabarsi, T.E. Tupasi, R. van Altena, M. Van der Walt, T.S. Van der Werf, M.H. Vargas, P. Viiklepp, J. Westenhouse, W.W. Yew, J.J. Yim and D. MenziesG.B. Migliori1WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyS. Ahuja2Bureau of Tuberculosis Control, New York City Department of Health and Mental Hygiene, Long Island City, United StatesD. Ashkin3Florida Department of Health, A.G. Holley Hospital, Lantana, United StatesM. Avendano4Tuberculosis Service, West Park Healthcare Centre, Toronto, CanadaR. Banerjee5Pediatric Infectious Diseases, Mayo Clinic, Rochester, United StatesM. Bauer6Montreal Chest Institute, McGill University, Montreal, CanadaJ. Bayona7Global Health Programs and Practice, The Dartmouth Center for Health Care Delivery Science, Hanover, United StatesM. Becerra8Department of Global Health & Social Medicine, Harvard Medical School, Boston, United StatesA. Benedetti6Montreal Chest Institute, McGill University, Montreal, CanadaM. Burgos9Department of Internal Medicine, Division of Infectious Diseases, University of New Mexico, Albuquerque, United StatesR. Centis1WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyE.D. Chan10Pulmonary Department, Denver Veterans Affair Medical Center; National Jewish Health, Denver, United StatesC.-Y. Chiang11International Union Against Tuberculosis and Lung Disease, Paris, France12Department of Internal Medicine, Wan Fang Hospital, School of Medicine, Taipei Medical University, Taipei City, TaiwanH. Cox13Médecins Sans Frontières, Cape Town, South AfricaL. D'Ambrosio1WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyK. DeRiemer14UC Davis School of Medicine, Davis, United StatesN.H. Dung15Pham Ngoc Thach Hospital for Tuberculosis and Lung Diseases, Ho Chi Minh City, Viet NamD. Enarson11International Union Against Tuberculosis and Lung Disease, Paris, FranceK. Flanagan16Launceston General Hospital, Tasmania, AustraliaJ. Flood17Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, United StatesM.L. Garcia-Garcia18Instituto Nacional de Salud Pública (INSP), Cuernavaca, MexicoN. Gandhi19Divisions of General Internal Medicine, Infectious Diseases, and Epidemiology, Albert Einstein College of Medicine, Division of General Internal Medicine, Montefiore Medical Center, Bronx, United StatesR. Granich20Antiretroviral Treatment and HIV Care, Department of HIV/AIDS, World Health Organization, Geneva, SwitzerlandM.G. Hollm-Delgado6Montreal Chest Institute, McGill University, Montreal, CanadaT.H. Holtz21HIV/STD Research Program, Thailand MOPH & US CDC Collaboration, Centers for Disease Control and Prevention, Atlanta, United StatesM. Iseman22Division of Mycobacterial and Respiratory Infections, Department of Medicine, National Jewish Health, Denver, United StatesL. Jarlsberg23Division of Pulmonary and Critical Care Medicine, San Francisco General Hospital, University of California, San Francisco, United StatesS. Keshavjee8Department of Global Health & Social Medicine, Harvard Medical School, Boston, United StatesH.R. Kim24Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, KoreaW.-J. Koh25Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaJ. Lancaster26Tuberculosis Epidemiology and Intervention Research Unit, South African Medical Research Council, Pretoria, South AfricaC. Lange27Clinical Infectious Diseases and Center for Clinical Studies, Medical Clinic, Tuberculosis Center, Borstel, GermanyW.C.M. de Lange28Department of Pulmonary Diseases & Tuberculosis, University Medical Center, Groningen, NetherlandsV. Leimane29s/a Infectology Center of Latvia, Clinic of Tuberculosis and Lung Diseases, Upeslejas, LatviaC.C. Leung30Department of Health, Tuberculosis and Chest Service, Hong Kong, ChinaJ. Li31New York City Department of Health and Mental Hygiene, NYC, United StatesS. Mishustin32Tomsk Oblast Tuberculosis Dispensary, Tomsk, Russian FederationC. Mitnick8Department of Global Health & Social Medicine, Harvard Medical School, Boston, United StatesM. Narita33Division of Pulmonary and Critical Care, University of Washington, Seattle, United StatesP. O'Riordan34City Road Medical Centre, London, United KingdomM. Pai6Montreal Chest Institute, McGill University, Montreal, CanadaD. Palmero35Pulmonology Division, Hospital F. J. Muñiz, Buenos Aires, ArgentinaS.K. Park36National Masan Tuberculosis Hospital, Masan City, KoreaG. Pasvol37Dept of Infection & Tropical Medicine, Imperial College London, London, United KingdomJ. Pena38Servicio de Medicina Interna, Hospital Universitario La Paz, Universidad Autonoma Madrid, Madrid, SpainC. Pérez-Guzmán39Instituto de Salud del Estado de Aguascalientes, and Unidad de Medicina Ambulatoria Aguascalientes, Instituto Mexicano del Seguro Social, Aguascalientes, MexicoM. Quelapio40Tropical Disease Foundation, Makati, PhilippinesA. Ponce-de-Leon41Instituto Nacional de Ciencias Médicas y de Nutrición “Salvador Zubirán”, Mexico D.F, MexicoV. Riekstina29s/a Infectology Center of Latvia, Clinic of Tuberculosis and Lung Diseases, Upeslejas, LatviaJ. Robert42Bactériologie-Hygiène - UPMC PARIS 6 - Site Pitié-Salpêtrière, Paris, FranceS. Royce43Global Health Sciences, University of California, San Francisco, United StatesH.S. Schaaf44Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Health Sciences, Stellenbosch University, Tygerberg, South AfricaK.J. Seung45Brigham and Women's Hospital, Boston, United StatesL. Shah6Montreal Chest Institute, McGill University, Montreal, CanadaT.S. Shim46Division of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, KoreaS.S. Shin47Division of Global Health Equity, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, United StatesY. Shiraishi48Section of Chest Surgery, Fukujuji Hospital, JATA, Tokyo, JapanJ. Sifuentes-Osornio41Instituto Nacional de Ciencias Médicas y de Nutrición “Salvador Zubirán”, Mexico D.F, MexicoG. Sotgiu49Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, ItalyM.J. Strand50Division of Biostatistics and Bioinformatics, National Jewish Health, Denver, United StatesP. Tabarsi51Mycobacteriology Research Center, NRITLD, Shaheed Beheshti Medical University, Tehran, Islamic Republic of IranT.E. Tupasi40Tropical Disease Foundation, Makati, PhilippinesR. van Altena28Department of Pulmonary Diseases & Tuberculosis, University Medical Center, Groningen, NetherlandsM. Van der Walt26Tuberculosis Epidemiology and Intervention Research Unit, South African Medical Research Council, Pretoria, South AfricaT.S. Van der Werf28Department of Pulmonary Diseases & Tuberculosis, University Medical Center, Groningen, NetherlandsM.H. Vargas52Instituto Nacional de Enfermedades Respiratorias, andUnidad de Investigación Médica en Enfermedades Respiratorias, Instituto Mexicano del Seguro Social., México DF, MexicoP. Viiklepp53Estonian Tuberculosis Registry, National Institute for Health Development, Tallinn, EstoniaJ. Westenhouse17Tuberculosis Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, United StatesW.W. Yew54Grantham Hospital, Hong Kong, ChinaJ.J. Yim24Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, KoreaD. Menzies6Montreal Chest Institute, McGill University, Montreal, Canada
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
